CR 500™ SINGLE-DOSE GEL

DEVICE2 trials

Sponsors

Contrad Swiss SA

Conditions

Knee Osteoarthritis

Unknown Phase

Evaluation of the Effect of the CR500 SINGLE-DOSE GEL Medical Device in Patients With Knee Osteoarthritis (KOA)

CompletedNCT05661162

Contrad Swiss SAKnee Osteoarthritis

Start: 2021-02-17End: 2021-05-18Updated: 2022-12-22

Retrospective Evaluation of the Long-term Effectiveness of the CR500™ SINGLE-DOSE GEL Medical Device in Patients With Knee Osteoarthritis (KOA)

CompletedNCT07322770

Contrad Swiss SAKnee Osteoarthritis

Start: 2025-02-17End: 2025-08-13Updated: 2026-01-07

Related Papers

Treatment with CR500® improves algofunctional scores in patients with knee osteoarthritis: a post-market confirmatory interventional, single arm clinical investigation

BMC Musculoskeletal Disorders2023-08-123 citations